Paris, France

Marie-Caroline Husson



 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marie-Caroline Husson: Innovator in Pharmaceutical Formulations

Introduction

Marie-Caroline Husson is a notable inventor based in Paris, France. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of gelling agents for medical applications. With a total of 2 patents, her work focuses on innovative solutions for pain treatment and burn care.

Latest Patents

One of her latest patents is a gelling formulation containing ketamine. This formulation includes ketamine or a pharmaceutically acceptable salt thereof, combined with water, a poloxamer, and one or more pharmaceutically acceptable mucoadhesive agents. The method of using this formulation is aimed at providing effective pain treatment. Another significant patent is a gelling formulation based on calcium gluconate. This invention relates to a gelling formulation that includes calcium gluconate in solution in water and a poloxamer, specifically designed for the treatment of hydrofluoric acid burns.

Career Highlights

Marie-Caroline Husson is associated with Assistance Publique-Hôpitaux de Paris, where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving patient care through innovative pharmaceutical solutions.

Collaborations

She collaborates with esteemed colleagues, including Vincent Boudy and Sandrine Graff De Faget, who contribute to her research endeavors.

Conclusion

Marie-Caroline Husson's contributions to pharmaceutical formulations highlight her innovative spirit and dedication to improving medical treatments. Her patents reflect a commitment to addressing critical healthcare challenges through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…